Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
36,654,668
-
Share change
-
-710,571
-
Total reported value
-
$394,020,592
-
Price per share
-
$10.75
-
Number of holders
-
105
-
Value change
-
-$12,842,306
-
Number of buys
-
56
-
Number of sells
-
44
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q1 2019
As of 31 Mar 2019,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,654,668 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, and BVF INC/IL.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.